S'abonner

The anti-leukemic activity of a luteolin-apigenin enriched fraction from an edible and ethnomedicinal plant, Elsholtzia stachyodes, is exerted through an ER stress/autophagy/cell cycle arrest/ apoptotic cell death signaling axis - 26/02/23

Doi : 10.1016/j.biopha.2023.114375 
Mattapong Kulaphisit a, b, 1, Kumpanat Pomlok a, b, Chalermpong Saenjum c, d, , Pitchaya Mungkornasawakul e, Kongkiat Trisuwan e, Jiraprapa Wipasa f, Angkana Inta b, Duncan R. Smith g, Pathrapol Lithanatudom b, c, , 1
a PhD Degree Program in Biology, Faculty of Science, Chiang Mai University, Chiang Mai, 50200, Thailand 
b Department of Biology, Faculty of Science, Chiang Mai University, Chiang Mai, 50200, Thailand 
c Center of Excellence for Innovation in Analytical Science and Technology for Biodiversity-based Economic and Society, Chiang Mai University, Chiang Mai 50200, Thailand 
d Department of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand 
e Department of Chemistry, Faculty of Science, Chiang Mai University, Chiang Mai, 50200, Thailand 
f Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, 50200, Thailand 
g Institute of Molecular Biosciences, Mahidol University, Nakhon Pathom, 73170, Thailand 

Corresponding author at: Department of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, 50200, Thailand.Department of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai UniversityChiang Mai50200Thailand⁎⁎Corresponding author at: Department of Biology, Faculty of Science, Chiang Mai University, 50200, Thailand.Department of Biology, Faculty of Science, Chiang Mai University50200Thailand

Abstract

Background

Elsholtzia is a genus in the family Lamiaceae, and some species in this genus are commonly used for food and in ethnomedicinal formulations by some ethnic groups of China and Thailand. Despite their apparent utility, few studies have been conducted to evaluate their potential as sources of medicinally active agents.

Purpose

We aimed to investigate the cytotoxicity of ethanolic extracts from three selected edible plant species of the genus Elsholtzia and the most promising extract was further characterized for the bioactive constituents and signaling mechanisms associated with the anti-leukemic activity.

Materials and methods

Ethanolic extracts were screened for cytotoxicity using flow cytometry. HPLC and LC-MS were used to analyze the chemical constituents of the most potent fraction from E. stachyodes. The relevant mechanism of action was assessed by western blot and multispectral imaging flow cytometry (MIFC).

Results

The most potent anti-leukemic activity was observed with the ethanolic extract from E. stachyodes. Luteolin and apigenin were characterized as the major constituents in the fraction from E. stachyodes. Mechanistically, the luteolin-apigenin enriched fraction (LAEF) induced the UPR, increased autophagic flux, induced cell cycle arrest and apoptotic cell death. LAEF showed significantly less cytotoxicity towards peripheral blood mononuclear cells (PBMCs) as compared to leukemia cell lines.

Conclusion

This study is the first to report E. stachyodes as a new source of luteolin and apigenin which are capable of triggering leukemic cell death. This could lead to a novel strategy against leukemia using ethnomedicinal plant extracts as an alternative or supplemental anti-cancer agent.

Le texte complet de cet article est disponible en PDF.

Graphical Abstract




ga1

Le texte complet de cet article est disponible en PDF.

Highlights

The genus Elsholtzia is commonly used for food and ethnomedicine by some northern Thai ethnic groups.
The ethanolic extract from Elsholtzia stachyodes showed the most potent anti-leukemic against three human leukemia cell lines.
Luteolin and apigenin were the major compounds found in the most potent anti-leukemic subfraction from the ethanolic extract of E. stachyodes.
Luteolin-Apigenin Enriched Fraction (LAEF) induced the UPR, autophagic flux, cell cycle arrest and apoptosis in U937.
LEAF exhibited less cytotoxicity towards healthy peripheral blood mononuclear cells (PBMCs) as compared to U937 cells.

Le texte complet de cet article est disponible en PDF.

Abbreviations : Akt, ATF-6, ATG5, ATP, CHOP, CML, c-Myc, DR5, EC, EG, ER, ERdj, ES, Fas/FasL, FADD, GRP78, Hsp90, LAEF, LAMP-1, LC3, MIFC, PARP, PBMCs, ROS, STAT3, UPR, XBP-1, XBP-1sp

Keywords : Elsholtzia, Luteolin, Apigenin, Anti-leukemic signaling, Multispectral imaging flow cytometry


Plan


© 2023  The Authors. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 160

Article 114375- avril 2023 Retour au numéro
Article précédent Article précédent
  • The single-chain relaxin mimetic, B7-33, maintains the cardioprotective effects of relaxin and more rapidly reduces left ventricular fibrosis compared to perindopril in an experimental model of cardiomyopathy
  • Fariha Alam, Tracey A. Gaspari, Barbara K. Kemp-Harper, Edward Low, Aaron Aw, Dorota Ferens, Iresha Spizzo, Ann-Maree Jefferis, Praveen Praveen, Robert E. Widdop, Ross A.D. Bathgate, Mohammed Akhter Hossain, Chrishan S. Samuel
| Article suivant Article suivant
  • Isoaaptamine increases ROS levels causing autophagy and mitochondria-mediated apoptosis in glioblastoma multiforme cells
  • Zhi-Hong Wen, Hsiao-Mei Kuo, Po-Chang Shih, Ling-Chen Hsu, Jimmy Ming-Jung Chuang, Nan-Fu Chen, Hsi-Wen Sun, Hsin-Tzu Liu, Chun-Sung Sung, Wu-Fu Chen

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.